Cargando…
Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model
Administration of dextran sodium sulfate (DSS) to rodents at varying concentrations and exposure times is commonly used to model human inflammatory bowel disease (IBD). Currently, the criteria used to assess IBD-like pathology seldom include surrogate measures of visceral pain. Thus, we sought to st...
Autores principales: | Ruiz, Henry H., Becker, Stephanie, Bai, Yu, Cortes-Burgos, Luz A., Eckersdorff, Melissa M., Macdonald, Lynn E., Croll, Susan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675069/ https://www.ncbi.nlm.nih.gov/pubmed/31369588 http://dx.doi.org/10.1371/journal.pone.0220156 |
Ejemplares similares
-
Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
por: Whittem, Caitlyn G., et al.
Publicado: (2010) -
Grim19 Attenuates DSS Induced Colitis in an Animal Model
por: Kim, Jae-kyung, et al.
Publicado: (2016) -
Tenascin-C is a driver of inflammation in the DSS model of colitis
por: Ozanne, James, et al.
Publicado: (2022) -
Ceramide Synthase 6 Deficiency Enhances Inflammation in the DSS model of Colitis
por: Helke, Kristi, et al.
Publicado: (2018) -
Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis
por: Chandrasekharan, Bindu, et al.
Publicado: (2008)